XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue $ 314,568 $ 280,317
Cost of goods sold 109,443 97,758
Gross margin 205,125 182,559
General and administrative expense 2,423,651 3,270,777
Operations expense 891,071 574,812
Sales and marketing expense 304,467 114,641
Total operating loss (3,414,064) (3,777,671)
Other income 42,430 28,259
Other expense (989) (234,972)
Gain on derivative instruments 1,908 95,671
Net loss $ (3,370,715) $ (3,888,713)
Loss per common share - basic and diluted (in dollars per share) $ (0.05) $ (0.11)
Weighted average shares used in computation - basic and diluted (in shares) [1] 65,835,080 36,513,300
[1] The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive: